CORRECTSEQ THERAPEUTICS Trademark
Trademark Overview
On Monday, January 17, 2022, a trademark application was filed for CORRECTSEQ THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CORRECTSEQ THERAPEUTICS trademark a serial number of 97222604. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 19, 2024. This trademark is owned by CorrectSequence Therapeutics Co., Ltd. The CORRECTSEQ THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system
Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes
General Information
Serial Number | 97222604 |
Word Mark | CORRECTSEQ THERAPEUTICS |
Filing Date | Monday, January 17, 2022 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Friday, July 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 30, 2023 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system |
Pseudo Mark | CORRECT SEQUENCE THERAPEUTICS |
NOT AVAILABLE | "THERAPEUTICS" |
Goods and Services | Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 21, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 21, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | CorrectSequence Therapeutics Co., Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Shanghai 200120 CN |
Party Name | CorrectSequence Therapeutics Co., Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Shanghai 200120 CN |
Trademark Events
Event Date | Event Description |
Thursday, January 20, 2022 | NEW APPLICATION ENTERED |
Friday, January 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 25, 2022 | ASSIGNED TO EXAMINER |
Friday, October 28, 2022 | NON-FINAL ACTION WRITTEN |
Friday, October 28, 2022 | NON-FINAL ACTION E-MAILED |
Friday, October 28, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, April 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, April 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 24, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
Thursday, January 25, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, January 25, 2024 | SOU EXTENSION 1 FILED |
Thursday, January 25, 2024 | SOU EXTENSION 1 GRANTED |
Saturday, January 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, July 19, 2024 | SOU TEAS EXTENSION RECEIVED |
Friday, July 19, 2024 | SOU EXTENSION 2 FILED |
Friday, July 19, 2024 | SOU EXTENSION 2 GRANTED |
Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |